Teacher Retirement System of Texas purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 48,086 shares of the company's stock, valued at approximately $3,293,000.
Other large investors have also added to or reduced their stakes in the company. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter worth approximately $32,000. Rakuten Securities Inc. acquired a new stake in Henry Schein during the first quarter worth approximately $34,000. Smartleaf Asset Management LLC grew its stake in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. UMB Bank n.a. grew its stake in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Finally, Menard Financial Group LLC bought a new position in Henry Schein in the fourth quarter worth approximately $92,000. Institutional investors and hedge funds own 96.62% of the company's stock.
Analyst Ratings Changes
Several research analysts have issued reports on HSIC shares. Piper Sandler cut their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research cut their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Evercore ISI increased their price target on Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a report on Wednesday. Finally, Wells Fargo & Company cut their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $79.70.
Get Our Latest Analysis on HSIC
Henry Schein Stock Down 1.5%
Shares of HSIC stock traded down $1.11 during trading hours on Friday, reaching $73.42. The company had a trading volume of 1,446,652 shares, compared to its average volume of 1,727,684. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. The business has a fifty day simple moving average of $71.56 and a 200-day simple moving average of $71.33. The company has a market cap of $8.94 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 2.37 and a beta of 0.87.
Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the company earned $1.10 earnings per share. The company's revenue for the quarter was down .1% on a year-over-year basis. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Henry Schein Company Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
